AIDS Therapy
Progress on HIV drug candidate PA-457 reported
Published in AIDS Weekly, April 21st, 2003
In an invited presentation at the 4th International Antiviral Drug Discovery and Development Summit in Princeton, New Jersey, the company described its plans to expedite development of PA-457, which is the first in a new class of HIV drugs called maturation inhibitors. Panacos scientists and their collaborators have demonstrated that PA-457 selectively blocks the last step in HIV maturation, a process that occurs as the virus buds from infected cells. Following PA-457 treatment, the released virus particles have a defective core structure and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-04-21)
More Articles from AIDS Weekly
- HIV/AIDS Pathogenesis
DC-SIGN has cell-type dependent role in viral entry - HIV/AIDS Vaccine
Immunization preserves helper T cell function in animals - AIDS Therapy
Collaboration identifies new class of agents with potential to treat HIV - HIV/AIDS Dementia
Tat antagonist inhibits gp-120-induced neuroblastoma cell death - HIV/AIDS Proteomics
Neutralizing epitope identified on C-terminal tail of gp41 - HIV/AIDS Vaccine
Tat protein and toxoid have similar immunogenicity - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
